文献速递乳腺乳腺X线

乳腺影像报告数据系统与对比增强乳腺摄影:病灶显著性与恶性可能性及与肿瘤受体状态的关系

Breast Imaging Reporting and Data System and Contrast Enhancement Mammography: Lesion Conspicuity Likelihood of Malignancy and Relationship With Breast Tumor Receptor Status.
PubMed 文献 · Acad Radiol · 2023-03-08

以活检组织学为金标准,中/高LC预测恶性时,经验最丰富医生基于低能图像判读的敏感度为91.9%(95%CI 88.6%-95.2%),特异度为67.2%(95%CI 58.9%-75.5%)。高LC与ER/PgR不表达(p=0.025)、Ki-67>20%(p=0.033)及G3分级(p=0.020)相关。

要点

  • CEM新增强化描述符「病灶显著性」中/高等级提示恶性,敏感度高但特异度中等。
  • 高病灶显著性需警惕ER/PgR不表达、Ki-67>20%及G3分级等侵袭性受体表型。
  • 判读低能图像时病灶显著性评估仍具较好敏感性,可辅助常规报告。

关键影像表现/征象

  • 病灶显著性(LC)为CEM新增强化描述符,分为缺失、低、中、高四级。
  • 中/高LC被视为恶性预测指标,基于低能图像判读时经验最丰富医生敏感度91.9%、特异度67.2%。

诊断标准与关键数值

  • 中/高LC预测恶性,以活检组织学为金标准,经验最丰富医生基于低能图像判读:敏感度91.9%(95%CI 88.6%-95.2%),特异度67.2%(95%CI 58.9%-75.5%)。
  • 高LC与ER/PgR不表达相关(p=0.025),与Ki-67>20%相关(p=0.033),与G3分级相关(p=0.020)。

临床应用与阅片要点

  • 在CEM报告中可描述病灶显著性等级,中/高等级提示恶性可能,需结合活检。
  • 高LC病灶应提示与侵袭性受体表型(ER/PgR不表达、高Ki-67、G3)的潜在关联。
  • 低能图像上评估LC仍可获得较高敏感性,但特异度有限,需注意假阳性。

局限性

  • 回顾性设计,可能存在选择偏倚。
  • 仅评估了病灶显著性这一新描述符,未与其他强化特征全面比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The new version of the Contrast Enhanced Mammography (CEM) Breast imaging Reporting and Data System (BIRADs) encourages investigations of a new enhancement descriptor: "Lesion Conspicuity" (LC). The study aims to assess the diagnostic performance and the relationship with the receptor profile of this new enhancement descriptor.

MATERIALS AND METHODS: Three hundred twenty-five patients with 381 breast lesions who underwent CEM before histological assessmentwere selected. Four radiologists, blinded to each other, categorized LC into the following levels: absent, low, moderate, and high. Considering moderate and high evaluations as predictive of malignancy, the diagnostic performance of CEM was calculated using histological results of the biopsy as the gold standard. The association between LC values and the receptor profile of the neoplasms was also evaluated.

RESULTS: The median age at the CEM examination was 50 years (IQR: 45-59). Considering the value of LC of the most experienced radiologist with the interpretation of Low Energy images (LE), we obtained a sensitivity (SE) of 91.9% (95% CI: 88.6%-95.2%) and a specificity (SP) of 67.2% (95% CI: 58.9%-75.5%). An association between "high" lesion conspicuity with ER/PgR not expressed (p = 0.025), with Ki-67>20% (p = 0.033), and with Grading G3 (p = 0.020) was observed.

CONCLUSION: The new feature of enhancement, "Lesion Conspicuity", demonstrated satisfactory performance in predicting the malignancy of lesions and significant correlation with the receptor profile of malignant breast neoplasms.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Nicosia, Bozzini, Palma, et al. Breast Imaging Reporting and Data System and Contrast Enhancement Mammography: Lesion Conspicuity Likelihood of Malignancy and Relationship With Breast Tumor Receptor Status. Acad Radiol. 2023. PMID: 36898907. doi:10.1016/j.acra.2023.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。